Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)
NCT01900197 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 391
Last updated 2016-03-02
Summary
The purpose of this study is to monitor and quality assure the efficacy and safety of Monofer® in a broad patient population when Monofer® is used according to the Monofer® label (SPC) in current practice and where standard routines are being followed.
Conditions
Interventions
- DRUG
-
10% Iron Isomaltoside 1000
Administered according to local routines and product labeling in doses at the doctors discretion
Sponsors & Collaborators
-
BioStata
collaborator INDUSTRY -
Pharmacosmos A/S
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
Countries
- Denmark
Study Locations
More Related Trials
-
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
NCT03188445 ·Status: COMPLETED ·Phase: PHASE4
-
Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients
NCT00117507 ·Status: COMPLETED ·Phase: PHASE4
-
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
NCT03237065 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
NCT00110266 ·Status: COMPLETED ·Phase: PHASE2
-
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
NCT03238911 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
NCT05179226 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency
NCT03181451 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
NCT00171821 ·Status: COMPLETED ·Phase: PHASE3
-
Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia
NCT01374919 ·Status: COMPLETED ·Phase: NA
-
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
NCT01394562 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients
NCT00529152 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
NCT04269707 ·Status: COMPLETED ·Phase: PHASE3
-
Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses
NCT01948817 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study
NCT01033747 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload
NCT02435212 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations
NCT01911871 ·Status: COMPLETED
-
A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia
NCT00399191 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients
NCT01825512 ·Status: COMPLETED ·Phase: PHASE3
-
A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload.
NCT00390858 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Deferiprone on Oxidative-Stress and Iron-Overload in Low Risk Transfusion-Dependent MDS Patients
NCT02477631 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
NCT01114139 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
NCT03079518 ·Status: COMPLETED ·Phase: PHASE2
-
Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
NCT00350662 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
NCT05927012 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia
NCT00703937 ·Status: COMPLETED ·Phase: PHASE3